Literature DB >> 30514999

Actinomycosis of the Middle Ear and Mastoid.

Mohammed Al Sheikh1, Saad Alenzi1, Asma Al Ahmadi1, Ali Mashragi1, Hoda Alsayid1, Alamri Abdullah1.   

Abstract

INTRODUCTION: Actinomycosis is a saprophytic infection caused by actinomycetes. Actinomycetes is a gram positive, anaerobic, non acid-fast, filamentous bacterium. Although actinomyce is considered as a part of the normal flora, it is rarely seen in middle ear and mastoid cavity. AIM: is to report a rare case of Actinomycosis infection of the middle ear and mastoid cavity. CASE REPORT: We presented A 24 years old male arrived to our outpatient department complaining of right-sided otalgia and hearing loss for 8 years, no history of otorreah, vertigo or dizziness. He had a history of right-sided chronic suppurative otitis media with a history of two operations at the same side. This report suggests that actinomycosis , although it is rare, it could occurs in middle ear. It should be considered as one of the differential for chronic suppurative otitis media patients with no improvement on medical treatment.
CONCLUSION: Combined medical and surgical treatment is the recommended management for Actinomycosis infection of the middle ear and mastoid cavity.

Entities:  

Keywords:  Actinomyces; Actinomycosis; Ear; Mastoid; Middle

Mesh:

Year:  2018        PMID: 30514999      PMCID: PMC6195014          DOI: 10.5455/medarh.2018.72.295-296

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


INTRODUCTION

Actinomycosis is a saprophytic infection caused by actinomycetes. Actinomycetes is a gram positive, anaerobic, non acid-fast, filamentous bacterium. Usually considered as apart of the normal flora. In human, actinomycosisisraeli is the most common pathogenic species of this bacteria. There are many important factors to be considered in pathogenesis of actinomycosis infections, such as trauma due to dental extraction, manipulation or caries. These factors provide an entry for these organisms to go deep into tissue where anaerobic conditions are necessary for their growth. It is commonly seen after minor trauma in cervicofacial region (55%) as well as the abdomen and thorax. Involvement of the middle ear and mastoid is rare and might be caused by direct spread via the eustachian tube from the nasopharynx.

CASE REPORT

A 24 years old male arrived to our outpatient department complaining of right-sided otalgia and hearing loss for 8 years, no history of otorreah, vertigo or dizziness. He had a history of right-sided chronic suppurative otitis media with a history of two operations at the same side, which were right side atticotomy combined with tympanoplasty in 2002 and right side tympanoplasty in 2007. Examination showed dull, intact tympanic membrane. Tuning fork showed mild conductive hearing loss. The rest of the examination was within normal. Audio-tympanogram showed mild conductive hearing loss in the right side and type B tympanogram. A computed tomography (CT) scan showed opacification of the right middle ear and mastoid as shown in Figure 1. Patient was admitted to the hospital and all pre-operative hematological, biochemical and serological investigations were within normal. Patient underwent exploratory right tympanatomy combined with right cortical mastoidectomy. Tissue specimens were sent for histopathology and comprehensive microbiology for aerobic, anaerobic, fungal and acid-fast bacillus cultures.
Figure 1.

Pre-operative CT scan showing middle ear and mastoid opacification

Histopathology showed acute and chronic inflammation with diffuse fibrosis. Acid-fast bacillus staining was negative and all microbiological cultures failed to grow any organisms. A Grocott-Gomori’s methenamine silver-nitrate stain (GMS stain) showed branching bacterial filaments as seen in Figure 2, allowing the diagnosis of actinomycosis to be established.
Figure 2.

Grocott-Gomori’s methenamine-silver nitrate stain showing cluster of branching bacterial filaments of actinomycosis

Patient had a history of Penicillin allergy. Consultations for both infectious diseases and allergy/immunology specialties were obtained to determine an optimal management strategy. He was started on Augmentin 1g and Doxycycline 200mg/day. Then, discharged in a stable condition on same medications with regular outpatient clinic appointments. During regular follow-up visits in outpatient clinic till up to date patient has no complaint, tympanic membrane looked normal. CT was done showed normal right middle ear and mastoid opacification as shown in Figure 3.
Figure 3.

Post-operative CT scan showing normal opacification of middle ear and mastoid

DISCUSSION

Actinomycosisis a subacute or chronic disease due to infection by actinomycesIsraeli, which is usually characterized by abscess formation, tissue fibrosis and draining sinuses. This commensal organism is found normally in high concentration in tonsils and carious teeth. It is considered as an opportunistic pathogen. In 1878, actinomycosis in human was first described by Israeli and Wlfeand. First, they isolated the causative agent in a culture. Then they defined the organism’s anaerobic nature. Before antibiotic era, diagnosis was often made at autopsy, as most of these infections were fatal because of their intracranial complications. Currently these cases usually presented as a chronic suppurative otitis media with prolonged course of treatment. In literature, most of these cases needed an intact canal wall tympanomastoidectomy followed by prolonged antibiotic treatment. Isolating actinomyces species from cultures of surgical specimen makes most accurate diagnosis. However, 70% of these cultures are negative because it is fastidious organism. Granules of actinomycosis strongly support the diagnosis, which are usually seen in histological examination. It is rarely visible on hematoxylin-eos in stained sections but can be seen as round or oval basophilic masses with a radiating arrangement of eosinophilic terminal “clubs”, Or using of other staining such as Grocott-gomori’s methenamine-silver nitrate stain, maccallen-good posture stain or brown-brenn stain and p-aminosalicylic acid. Combination of medical and surgical treatment is recommended. Surgery is performed first for mechanical debridement of the affected area to reduce bacterial load. Followed by prolonged course of medical therapy. Recommended treatment regimes vary from six weeks to one year depending on the site and severity of the infection. Actinomyces species are usually susceptible to a number of antimicrobials therapies. Including Penicillin, Chloramphenicol, Tetracyclines, Erythromycin, Clindamycin, Streptomycin, Imipenem and Cephalosporins. Prolonged observation is necessary to detect recurrences.

CONCLUSION

Although actinomyce is considered as a part of the normal flora, it is rarely seen in middle ear and mastoid cavity. This study suggests that actinomycosis, although it is rare, it could occurs in middle ear. It should be considered as one of the differential for chronic suppurative otitis media patients with no improvement on medical treatment. Combined medical and surgical treatment is the recommended management.
  7 in total

1.  Actinomycosis otitis media.

Authors:  C Shelton; D E Brackmann
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-01

2.  A clinical and microbiological study of Actinomycetes in oral and cervicofacial lesions.

Authors:  R H Samuels; M V Martin
Journal:  Br J Oral Maxillofac Surg       Date:  1988-12       Impact factor: 1.651

3.  Actinomycosis of the tympanomastoid.

Authors:  J H Leek
Journal:  Laryngoscope       Date:  1974-02       Impact factor: 3.325

4.  Actinomycosis of the middle ear.

Authors:  T S Olson; A B Seid; S M Pransky
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1989-02       Impact factor: 1.675

5.  Actinomycosis. Surgical aspects.

Authors:  L F Harris; P R Kakani; C E Selah
Journal:  Am Surg       Date:  1985-05       Impact factor: 0.688

6.  Cervicofacial actinomycosis.

Authors:  L J Bartels; D P Vrabec
Journal:  Arch Otolaryngol       Date:  1978-12

7.  Actinomycosis of the larynx.

Authors:  S O Shaheen; F G Ellis
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.